Previous 10 | Next 10 |
Results from a new study showed that end-of-year drug approvals by the FDA are linked to more hospitalizations, life-threatening events and deaths, a rate about twice as high as medicines approved earlier in the year. More news on: ProShares Trust - ProShares Ultra Nasdaq Biotechnology,...
Reuters reports that pharmaceutical companies, including Pfizer (NYSE: PFE ), GlaxoSmithKline (NYSE: GSK ) and Sanofi (NASDAQ: SNY ), are planning to raise prices on more than 200 medicines in the U.S. tomorrow. More news on: Pfizer Inc., GlaxoSmithKline plc, Sanofi, Healthcare stocks ne...
Co-produced by Stanford Chemist . This article was originally published on November 23, 2019. We previously covered the topic of analyzing fixed-income and preferred stock distribution sustainability. Looking at NII trends and interest rate impacts to gauge the continuation of a rate. W...
On Monday of this week I did a fairly large re-balancing (for me) of the PPRP, selling two large closed-end fund holdings and replacing them with six stocks and CEFs. While these transactions might not be "major" for some of you, they represented a big step for me, considering my conservative ...
The U.S. 5th Circuit Court of Appeals in New Orleans has ruled the the individual mandate of the Affordable Care Act (ACA), also known as Obamacare, is unconstitutional . More news on: Tekla World Healthcare Fund, BlackRock Health Sciences Trust, The Gabelli Healthcare & Wellness Rx T...
By a 230-192 margin, the U.S. House of Representatives has passed legislation , championed by Speaker Nancy Pelosi, aimed at corralling spiralling drug costs. More news on: ProShares Trust - ProShares Ultra Nasdaq Biotechnology, Tekla World Healthcare Fund, ARK Genomic Revolution Multi-Se...
If you're looking to "go with the flow," you may want to take a closer look at the healthcare sector. After being a steadily outperforming sector for many years, healthcare began lagging other sectors in Q4 '18 and for much of 2019. But since October 2019, healthcare has turned around dram...
This article was originally published on October 29, 2019. Most closed-end fund investors know that distribution cuts come with the nature of the closed-end fund's structure. The fact is that when a fund is paying out 90% of their NII and 98% of their realized capital gains on an annual ba...
I still believe that a correction is coming; however, I think there are limited opportunities in today's market. That said, I have not made any significant changes to the sector allocations presented in the last article . The one change I am thinking about making is to increase the allocati...
For quite some time now, I have suggested that every investor maintain some type of exposure to the healthcare industry. There are a few reasons for this including the industry's generally defensive nature and the considerable growth potential that it boasts. There are a number of ways to inve...
News, Short Squeeze, Breakout and More Instantly...
Tekla World Healthcare Fund Shares of Beneficial Interest Company Name:
THW Stock Symbol:
NYSE Market:
There’s nothing we closed-end fund investors love more than finding a smartly run fund in an unfairly beaten-down sector. This hands us a nice discount (of course!), plus a much bigger dividend, because yields and prices move in opposite directions. In fact, with CEFs, we...
Most investors are ignoring a clear shot at 7%+ dividends double-digit price gains—year in and year out—in a sector everyone should be talking about, but isn’t. That would be healthcare, which is riding a rocket of rising spending: according to the latest number...
Tekla World Healthcare Fund (the “Fund”) (NYSE: THW) is pleased to announce the completion of its one for three non-transferable rights offering (the “Offering”) which expired Tuesday, April 6, 2021 (the “Expiration Date”). Pursuant to the Offer...